Heptapeptide Libraries: A High-Throughput Path to Drug Discovery

I. Overview

Heptapeptide libraries are key combinatorial tools for discovering bioactive ligands. Their moderate length offers structural diversity, while the physical linkage between peptide phenotype and genotype enables rapid identification of high-affinity binders to specific targets via high-throughput screening. This efficiently generates leads for biopharmaceutical development.

II. Screening Principle

Screening employs “biopanning.” Random heptapeptides, fused to phage coat proteins, are incubated with an immobilized target. Weak binders are removed by stringent washing. Bound phages are eluted, amplified in bacteria, and the process is repeated over 3-5 rounds to enrich high-affinity clones. Next-generation sequencing then identifies the heptapeptide sequences.

III. Screening Methods

Two primary methods are used:

Solid-Phase Screening

The target is immobilized on a surface (e.g., plates, beads). It is simple but may alter protein conformation.

Solution-Phase Screening

The target is biotinylated in solution. Complexes with peptides are captured on streptavidin beads, preserving native conformation for more physiologically relevant screening.

IV. Screening Process

A multi-round enrichment process is used:

Binding

Library is incubated with the target.

Washing

Unbound/weakly bound phages are removed.

Elution

Specifically bound phages are recovered.

Amplification

Eluted phages are amplified for the next round. Stringency increases over 3-5 rounds.

Analysis

Enriched pools are sequenced, and dominant peptides are synthesized for validation.

V. Affinity Validation

Candidate peptides require quantitative affinity validation:

ELISA

Measures EC50 for initial affinity assessment.

SPR

Provides real-time kinetics (ka, kd, KD).

BLI

A high-throughput alternative for measuring binding kinetics.

Read More!

Alpha Lifetech, leveraging its mature Phage Display Peptide Library Construction Platform and Phage Display Peptide Library Screening Platform, provides high-quality phage display libraries with capacities up to 10^12, ensuring the identification of ligands with affinities reaching the nM or even pM range.

Leave a Reply

Your email address will not be published. Required fields are marked *